HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicoletta D'Alessandris Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

10/2023Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
9/2021Depth of Stromal Invasion as the Most Prognostically Relevant Regression System in Locally Advanced Cervical Cancer after Neoadjuvant Treatment: A Systematic Review and Meta-Analysis Grading.
3/2021PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer.
3/2021Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.
12/2020Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicoletta D'Alessandris Research Topics

Disease

14Neoplasms (Cancer)
01/2024 - 11/2019
6Endometrial Neoplasms (Endometrial Cancer)
01/2024 - 01/2021
5Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2023 - 12/2020
5Carcinoma (Carcinomatosis)
11/2022 - 08/2020
3Neoplasm Metastasis (Metastasis)
06/2023 - 12/2020
2Turcot syndrome
01/2024 - 12/2021
2Endometrioid Carcinoma
11/2022 - 07/2022
1Breast Neoplasms (Breast Cancer)
06/2023
1Inflammation (Inflammations)
03/2023
1Metaplasia
08/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020
1Adenosquamous Carcinoma
12/2020
1Adenocarcinoma
12/2020
1Neurothekeoma
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019
1Pleural Effusion (Pleural Effusions)
11/2019
1Lymphoma (Lymphomas)
11/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2019

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2022
2AntigensIBA
08/2020 - 11/2019
1LigandsIBA
01/2024
1MucinsIBA
06/2023
1HemosiderinIBA
03/2023
1alpha-methylacyl-CoA racemaseIBA
08/2022
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
07/2022
1Carrier Proteins (Binding Protein)IBA
04/2022
1AerosolsIBA
01/2022
1CateninsIBA
12/2021
1VimentinIBA
12/2021
1PlatinumIBA
03/2021
1Sucrose (Saccharose)IBA
01/2021
1Nucleic AcidsIBA
12/2020
1Eosine Yellowish-(YS) (Eosin)IBA
12/2020
1Hematoxylin (Haematoxylon)IBA
12/2020
13-hydroxy-5-estrane-17-carbonitrile (ACN)IBA
12/2020
1mesoglycanIBA
08/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1CaspasesIBA
01/2020

Therapy/Procedure

4Immunotherapy
01/2024 - 01/2020
4Drug Therapy (Chemotherapy)
11/2022 - 01/2020
4Neoadjuvant Therapy
01/2022 - 03/2021
2Therapeutics
11/2022 - 05/2021
1Radiotherapy
10/2023
1Hysterectomy
12/2022
1Operative Surgical Procedures
12/2020
1Breast Implants (Breast Implant)
11/2019